Crossmark

Virtual screening reveals aprepitant to be a potent inhibitor of neutral sphingomyelinase 2: implications in blockade of exosome release in cancer therapy

Crossref DOI link: https://doi.org/10.1007/s00432-023-04674-6

Published Online: 2023-03-08

Published Print: 2023-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Moloudizargari, Milad

Hekmatirad, Shirin

Gharaghani, Sajjad

Moghadamnia, Ali Akbar

Najafzadehvarzi, Hossein

Asghari, Mohammad Hossein https://orcid.org/0000-0003-2981-879X
Funding

Funding for this research was provided by:

Babol University of Medical Sciences
License Information

Text and Data Mining valid from 2023-03-08

Version of Record valid from 2023-03-08
More Information

Article History

Received: 6 February 2023

Accepted: 1 March 2023

First Online: 8 March 2023

Declarations

:

: The authors declare that there are no conflicts of interest.

Document is current

Any future updates will be listed below